137 related articles for article (PubMed ID: 26342564)
21. Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure.
Xue Y; Taub P; Iqbal N; Fard A; Clopton P; Maisel A
Eur J Heart Fail; 2013 Dec; 15(12):1343-9. PubMed ID: 23887059
[TBL] [Abstract][Full Text] [Related]
22. Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.
Odermatt J; Meili M; Hersberger L; Bolliger R; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
BMC Cardiovasc Disord; 2017 Jul; 17(1):178. PubMed ID: 28676115
[TBL] [Abstract][Full Text] [Related]
23. Mid-regional-pro-adrenomedullin plasma levels are increased in obese adolescents.
Del Ry S; Cabiati M; Bianchi V; Caponi L; Di Cecco P; Marchi B; Randazzo E; Caselli C; Prescimone T; Clerico A; Federico G
Eur J Nutr; 2016 Apr; 55(3):1255-60. PubMed ID: 26018656
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.
Liu D; Xie L; Zhao H; Liu X; Cao J
BMC Infect Dis; 2016 May; 16():232. PubMed ID: 27230573
[TBL] [Abstract][Full Text] [Related]
25. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of mid-regional pro-adrenomedullin in sepsis are associated with risk of death.
Valenzuela-Sánchez F; Valenzuela-Méndez B; Bohollo de Austria R; Rodríguez-Gutiérrez JF; Estella-García Á; Fernández-Ruiz L; González-García MÁ; Rello J
Minerva Anestesiol; 2019 Apr; 85(4):366-375. PubMed ID: 30207133
[TBL] [Abstract][Full Text] [Related]
27. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
[TBL] [Abstract][Full Text] [Related]
28. Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study.
Gar C; Thorand B; Herder C; Sujana C; Heier M; Meisinger C; Peters A; Koenig W; Rathmann W; Roden M; Stumvoll M; Maalmi H; Meitinger T; Then H; Seissler J; Then C
PLoS One; 2022; 17(1):e0262330. PubMed ID: 34990470
[TBL] [Abstract][Full Text] [Related]
29. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
[TBL] [Abstract][Full Text] [Related]
30. Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality.
Artunc F; Nowak A; Mueller C; Breidthardt T; Twerenbold R; Wagner R; Peter A; Haering HU; Ebmeyer S; Friedrich B
PLoS One; 2014; 9(1):e86148. PubMed ID: 24465926
[TBL] [Abstract][Full Text] [Related]
31. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.
Bellia C; Agnello L; Lo Sasso B; Bivona G; Raineri MS; Giarratano A; Ciaccio M
Clin Chem Lab Med; 2019 Mar; 57(4):549-555. PubMed ID: 30157027
[TBL] [Abstract][Full Text] [Related]
32. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
Morgenthaler NG; Struck J; Alonso C; Bergmann A
Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
[TBL] [Abstract][Full Text] [Related]
33. Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study.
Graziadio S; O'Leary RA; Stocken DD; Power M; Allen AJ; Simpson AJ; Price DA
BMJ Open; 2019 Feb; 8(11):e020337. PubMed ID: 30798282
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Midregional Pro-Adrenomedullin and High-Sensitivity Troponin T Predict Perioperative Cardiovascular Events in Noncardiac Surgery.
Golubović M; Janković R; Sokolović D; Ćosić V; Maravić-Stojkovic V; Kostić T; Perišić Z; Lađević N
Med Princ Pract; 2018; 27(3):278-284. PubMed ID: 29514145
[TBL] [Abstract][Full Text] [Related]
35. Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial.
Möckel M; Searle J; Hartmann O; Anker SD; Peacock WF; Wu AH; Maisel A; ; Slagman A; Vollert JO; Papassotiriou J; Anand I; Christenson R; Daniels LB; Filippatos GS; Hogan C; Morgenthaler N; Mueller C; Neath SX; Ng L; Nowak R; Richards M; Di Somma S; Ponikowski P
Emerg Med J; 2013 Aug; 30(8):633-7. PubMed ID: 22962091
[TBL] [Abstract][Full Text] [Related]
36. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
[TBL] [Abstract][Full Text] [Related]
37. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
38. Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study.
Vigué B; Leblanc PE; Moati F; Pussard E; Foufa H; Rodrigues A; Figueiredo S; Harrois A; Mazoit JX; Rafi H; Duranteau J
Crit Care; 2016 Nov; 20(1):363. PubMed ID: 27825364
[TBL] [Abstract][Full Text] [Related]
39. Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.
Parwani AS; von Haehling S; Kolodziejski AI; Huemer M; Wutzler A; Attanasio P; Stojakovic T; Scharnagl H; Haverkamp W; Boldt LH
Int J Cardiol; 2015 Feb; 180():129-33. PubMed ID: 25438233
[TBL] [Abstract][Full Text] [Related]
40. Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes.
Velho G; Ragot S; Mohammedi K; Gand E; Fraty M; Fumeron F; Saulnier PJ; Bellili-Munoz N; Bouby N; Potier L; Alhenc-Gelas F; Marre M; Hadjadj S; Roussel R
Diabetes; 2015 Sep; 64(9):3262-72. PubMed ID: 25948679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
